Industry

Food culture and gut health: a initiative to define the frame for consistent evidence

François Bourdichon presents the IDF's initiative of defining standards and putting a frame beyond probiotics.

Lallemand’s L. rhamnosus HA-114 supports during a weight management program

Brunella V. Gonzales Cautela (Lallemand) discusses the impact of L. rhamnosus HA-114 on a weight loss program for people suffering of obesity and overweight.

The IPA Track Day: take home message from the 11th Probiotics, Prebiotics & New foods Congress

Interview with George Paraskevakos, Executive Director at International Probiotics Association.

IPA Europe, regulatory, scientific and consumer perspective on probiotics

Several angles were raised, in Europe and Worldwide, during the 11th edition of the International Congress Probiotics, Prebiotics and New Foods.

Amandine Brochot – Akkermansia muciniphila: ‘How we developed the first next generation probiotic’

Amandine Brochot from A-Mansia Biotech tells us about the development of the first next-generation probiotic: Akkermansia muciniphila.

Sacco System to Support Breakthrough Research on Infant Gut Health with Evivo®, the Baby Probiotic

Sacco System will support Evolve BioSystems Inc with an investment finalized to eventually bring Evivo® Baby Probiotic to Europe.

A-Mansia Biotech’s pasteurised Akkermansia muciniphila is the first next generation bacterium to get green light from EFSA’s scientific council

A milestone for people at risk of cardiovascular disease, obesity and diabetes: the new ingredient will be marketed as a food supplement in 2022

Colgate-Palmolive signs on as Headline Partner for Microbiome Connect: Oral USA

The 3rd Edition Marketsandmarkets Next Gen Microbiome and Probiotics - Virtual Conference, scheduled to be held on 25th and 26th February 2021 will go live to unite global industry attendees…

Microbiome Insights Laboratory receives accreditation from the College of American Pathologists

The 3rd Edition Marketsandmarkets Next Gen Microbiome and Probiotics - Virtual Conference, scheduled to be held on 25th and 26th February 2021 will go live to unite global industry attendees…

Matthew Henn (Seres Therapeutics): ‘Microbiome research will have a large impact on human health’

Watch our interview with Matthew Henn, Executive Vice President and Chief Scientific Officer of Seres Therapeutics.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top